Fish Oil Feed

Promoting and maintaining a state of wellness requires a dynamic balance of hormones known as eicosanoids.*  Eicosanoids are powerful cell regulators that help maintain virtually all body functions including the brain, the heart and the immune system.*  Daily supplementation with pharmaceutical- grade fish oils rich in the long-chain omega-3 essential fatty acids, EPA and DHA, is critical for maintaining optimal eicosanoid balance throughout the body.

According to Dr. Sears, ultra-refined grade fish oil has some very distinct characteristics:

• Concentration of EPA and DHA > 60%
• Concentration of PCB's < 45 ppb/g
• Concentration of Dioxins < 1 ppt
• Concentration of Mercury <10 ppb

Because of these rigid and exacting specifications, the supply of this type of fish oil is very limited since it takes 100 gallons of health-food grade fish oil to make one gallon of pharmaceutical- grade fish oil.

Although this more refined fish oil costs 10-20 times more than health-food grade, we keep our price per gram of EPA and DHA as low as possible as shown below.

OmegaRxTM
Ultra-Refined
Fish Oil



8 fl oz bottle
(45 day supply)
Retail $78.15
Autoship $62.50

120 capsules
(30 day supply)
Retail $50.00 
Autoship $40.00

Why OmegaRxTM
Ultra-Refined Grade Fish Oil?

• It is so pure and refined, it contains hundreds of times less PCB's than health food grade fish oil.
• It has twice the EPA and DHA (substances necessary to affect your eicosanoid balance) potency as found in health-food grade fish oil.
• Most people will not experience mild gastric upsets often found with high doses of health-food grade fish oil.
• We believe you'll never find this quality of fish oil in any health food store, nor from any direct mail company.

Ingredients: marine lipid concentrate, lime flavor, and natural mixed tocopherols.

One teaspoon of the liquid OmegaRxTM contains 2.7grams of long-chain omega-3 fatty acids (1.8 grams of EPA and 0.9 grams of DHA). Four capsules of contain 2.4 grams of long-chain omega-3 fatty acids (1.6 grams of EPA and 0.8 grams of DHA). For comparison purposes, one tablespoon of cod liver oil contains approximately 2.5 grams of long-chain omega-3 fatty acids.

Type of Fish Oil
Compare Cost Per Gram Price Per
Gram of
EPA & DHA Lowest grade health-food grade $0.30 Molecular distilled health-food grade $0.54 OmegaRxTM  capsules $0.56 OmegaRxTM liquid oil $0.49

  "High-dose pharmaceutical grade fish oil is as close to a medical miracle as we will see in the 21st century."
Dr Barry Sears
   

Pharmaceutical Grade Fish Oil
20% off with autoship

 
see special below!
 

 

30 Day
Money Back Guarantee

• 8 Fl Oz Bottle (45 day supply)
  Retail $78.15 - Autoship $62.50
   
• 120 Capsules - 1000mg  (30 day supply)
  Retail $50.00 - Autoship $40.00
   
• 240 Micro Caps - 500mg  (30 day supply)
  Retail $52.00 - Autoship $41.60

 

Scientific Evidence Reveals a Diet Rich in Long-Chain Omega-3 Fatty Acids Helps Support

• A Healthy Brain

• A Healthy Heart

• A Healthy Immune System

• Healthy Joint Movement

• Healthy Kidneys

• Balanced Mood

• Sense of Well Being

• Strength and Stamina

• And Helps Maintain Cholesterol Levels that are Already within the Normal Range*

Click here to Listen to the 3 minute audio by Dr. Barry Sears about Pharmaceutical Grade Fish Oil

       

 

Fish Oil & Omega-3 Fatty Acids

Dr. Barry Sears is a research scientist and author of the best selling Zone Diet books. After twenty years of research he released the book "The Omega Rx Zone - The Miracle of the New High-Dose Fish Oil". It is loaded with information about the benefits of long-chain omega-3 fatty acids of the type found in fish oils. It was Dr. Sears who created pharmaceutical grade fish oil. OmegaRx is a highly refined nutritional supplement containing generous quantities of the omega-3 fatty acids EPA and DHA.     Scientists discovered that Greenland Eskimos rarely develop coronary heart disease even though they consume a great deal of fat. Sea mammals and other seafood provide most of the fat in their diet including significant quantities of long-chain omega-3 fatty acids. Dr. Barry Sears OmegaRx Fish Oil contains these same essential omega-3 fatty acids.     It is recommended by the American Heart Association that healthy people protect their heart by consuming omega-3 fatty acids from plant and fish sources.     Studies: Extensive research has been completed on the function of essential fatty acids in the mind and body. This includes hundreds of clinical studies and thousands of scientific studies about omega-3 fatty acids..     Purity: OmegaRx Ultra Refined Fish Oil is hundreds of Times More Pure and Twice as Potent as Health Food Grade Fish Oil. According to Dr. Sears the fish oils available at health food stores and the cod liver oil used for generations is not pure enough to feel all the potential benefits. Omega Rx is high potency, the dangerous toxins have been removed, and clinical testing has produced encouraging results. It is a highly purified, pharmaceutical grade, ultra refined fish oil.     Zone Books: In addition to the Omega Rx Zone, Dr. Barry Sears has written a number of Zone related books including The Anti-Inflammation Zone, The Anti-Aging Zone, Zone-Perfect Meals in Minutes, Zone Food Blocks, Mastering the Zone, A Week in the Zone, The Soy Zone and The Top 100 Zone Foods. In his latest two books The OmegaRx Zone and The Anti-Inflammation Zone Dr. Sears makes it easy to follow The Zone Diet by dividing your plate into sections and filling each with a certain type of food. He also describes why a pharmaceutical grade fish oil like Omega Rx is the most important nutritional supplement you can take.     Capsules: The suggested usage for Dr. Barry Sears Omega Rx Fish Oil Capsules is 4 per day. This provides 2.4 grams of omega-3 fatty acids with 1600 mg of EPA and 800 mg of DHA. Each 1000 mg capsule of pharmacy grade fish oil contains 600 mg of long chain omega-3 fatty acids including 400 mg EPA and 200 mg DHA. The bottle contains 120 capsules and will last for 30 days.     Microcaps: These are half the size of capsules and easier to swallow. The suggested usage is 8 per day. This provides 2.4 grams of omega-3 fatty acids with 1600 mg of EPA and 800 mg of DHA. Each 500 mg capsule of pharmacy grade fish oil contains 300 mg of long chain omega-3 fatty acids including 200 mg EPA and 100 mg DHA. The bottle contains 240 microcaps and will last for 30 days.     Liquid: The suggested usage for Dr. Sears Omega Rx Zone Fish Oil Liquid is one teaspoon per day. This provides 2.7 grams of long chain omega-3 fatty acids including 1.8 grams EPA and 0.9 grams DHA. The bottle contains 8 oz of fish oil concentrate and lasts for 45 days. If the usage is increased to one tablespoon per day each bottle will last for 15 days.     Fish oil for kids: The suggested usage for children 4 years of age and older is the same as adults.     Source: Omega Rx is made from the fish body oil of sardines, anchovies and mackerel. These fish are small and low on the food chain so they contain less toxins. They also multiply rapidly and are replenished in the ocean quickly creating a more sustainable ecosystem.

 

Dr Sears Wellness Pack Sale

Purchase OmegaRx & SeaHealth:
Receive Free Zone Book
(Free Zone Book while supplies last.)

• 1 Bottle OmegaRx Fish Oil
   

• 1 Bottle SeaHealth Plus with Natural Trace Minerals and Powerful Anti-Oxidants
   

• Free Anti-Aging Zone Book by Dr Barry Sears valued at $25

Special Fish Oil and Seahealth Plus Package
 

Helps Support A Healthy Brain

Burgress, J. R., L. Stevens, and L. Peck. "Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder." Am J Clin Nutr 71:327S-330S (2000).

Connor, W. E., M. Neuringer, and D. S. Lin. "Dietary effects on brain fatty acid composition: The reversibility of n-3 fatty acids deficiency and turnover of docosahexaenoic acid in the brain erythrocytes and plasma of rhesus monkeys." J Lipid Res 31:237-247 (1990).

Connor, W. E., M. Neuringer, and S. Reisbick. "Essential fatty acids: Importance of n-3 fatty acids in the retina and brain." Ntr Rev 50:21-29 (1992).

Conquer, J. A., M. C. Tierney, J. Zecevic, W.J. Bettger, and R.H. Fisher. "Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment." Lipids 35:1305-1312 (2000).

Fenton W. ., Dickerson F., Boronow J., Hibbeln J. R., Knable M. “A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia.” Am J Psychiatry 158(12):2071-4 (2001).

Gamoh, S., M. Hashimoto, K. Sugioka, S. Hossain, N. Hata, Y. Misawa, and S. Masumura. "Chronic administration of docosahexaenoic acid improves reference memory-related learning ability in young rats." Neurosci 93:237-241 (1999).

Jones, C. R., T. Aria, and S. I. Rapoport. "Evidence for the involvement of docosahexaenoic acid in cholinergic simulated signal transduction at the synapse." J Neurochem Res 22:663-670 (1997).

Katzman, R., and J. E. Jackson. "Alzheimer disease: Basic and clinical advances." J Am Geriatrics Soc 39:516-525 (1991).

Kodas E., Page G., Zimmer L., Vancassel S., Guilloteau D., Durand G., Chalon S. "Neither the density nor function of striatal dopamine transporters were influenced by chronic n-3 polyunsaturated fatty acid deficiency in rodents.” Neurosci Lett 321(1-2):95-9 (2002).

Kyle, D. J., E. Schaefer, G. Patton, and A. Beiser. "Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia." Lipids 34:S245 (1999).

Lauritzen, I., N. Blondeau, C. Heurteaux, C. Widmann, G. Romey, and M. Lazdunski. "Polyunsaturated fatty acids are potent neuroprotectors." EMBO J 19:1784-1793 (2000).

Lauritzen, L., H. S. Hansen, M. H. Jorgensen, and K. F. Michaelsen. "The essentiality of long-chain n-3 fatty acids in relation to development and function of the brain and retina." Prog Lipid Res 40:1-94 (2001).

Marangell L B, Martinez J M, Zboyan H A, Kertz B, Kim H F, Puryear L J. “A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression.” Mood Disorders Center, Department of Psychiatry, Baylor College of Medicine, Houston, TX, USA.

Schiefermeier M., Yavin E. “n-3 Deficient and docosahexaenoic acid-enriched diets during critical periods of the developing prenatal rat brain.” J Lipid Res 43(1):124-31 (2002).

Sonderberg, M., C. Edlund, K. Kristensson, and G. Dallner. "Fatty acid composition of brain phospholipids in aging and Alzheimer's disease." Lipids 26:421-423 (1991).

Stevens, L. J., and J. Burgess. "Omega-3 fatty acids in boys with behavior, learning, and health problems." Physiol Behav 59:915-920 (1996).

Stevens, L. J., S. S. Zentall, J. L. Deck, M. L. Abate, B. A. Watkins, S. A. Lipp, and J. R. Burgess. "Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder." Am J Clin Nutr 62:761-768 (1995).

Stordy, B. J. "Benefit of docosahexaenoic acid supplements to dark adaption in dyslexics." Lancet 346:385 (1995).

Terano, T., S. Fujishiro, T. Ban, K. Yamamoto, T. Tanaka, Y. Noguchi, Y. Tamura, K. Yazawa, and T. Hirayama. "Docosahexaenoic acid supplementation improves moderately severe dementia from thromboitc cerebrovascular diseases. Lipids 34:S345-S346 (1999).

Voigt, R. G., A. M. Llorente, C. L. Jensen, J. K. Fraley, M.C. Berretta, and W. C. Heird. "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder." J Pediatr 139:189-196 (2001).

Vance, H. E., R. B. Campenot, and D. E. Vance. "The synthesis and transport of lipids for axonal growth and nerve regeneration." Biochim Biophys Acta 1486:84-96 (2000).

Yeh, Y. Y., M. F. Gehman, and S. M. Yeh. "Maternal dietary fish oil enriches docosahexaenoate levels in brain subcellular fractions of offspring." J Neurosci Res 35:218-226 (1993).

Yehuda, S., S. Rabinovitz, R.L. Carasso, and D.I. Mostofsky. "Essential fatty acid preparation improves Alzheimer's patients' quality of life." Int J Neurosci 87:141-149 (1996).

Willatts, P., J. S. Forsyth, M. K. DiModugno, S. Varma, and M. Colvin. “Effect of long-chain polyunsaturated fatty acids in infant formula on problem solving at 10 months of age.” Lancet 352:688-691 (1998).

Helps Support A Healthy Heart

Albert, C. M., C. H. Hennekens, C.I. O'Donnel, U. A. Ajani, V. J. Carey, and W. C. Willett. "Fish consumption and risk of sudden cardiac death." JAMA 279:23-28 (1998).

Angerer P., Kothny W., Stork S., von Schacky C. “Effect of dietary supplementation with omega-3 fatty acids on progression of atherosclerosis in carotid arteries.” Klinikum der Universitat Munchen, Institut und Poliklinik fur Arbeits- und Umweltmedizin-Innenstadt, Ziemssenstrasse 1, Germany.

Appel, Lawrence J., et al. “Does supplementation of diet with "fish oil" reduce blood pressure?” Archives of Internal Medicine 153:1429-38 (1993).

Christensen, J. H., M. S. Christensen, J. Dyerberg, and E. B. Schmidt. "Heart rate variability and fatty acid content of blood cell membranes: A dose-response study with n-3 fatty acids." Am J Clin Nutr 70:331-337 (1999).

Christensen, Jeppe Hagstrup, et al. “Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. “ American Journal of Clinical Nutrition 70:331-37 (1999).

Christensen, Jeppe Hagstrup, et al. “Effect of fish oil on heart rate variability in survivors of myocardial infarction. “ British Medical Journal 312:677-78 (1996).

Christensen, Jeppe Hagstrup, et al. “Heart rate variability and fatty acid content of blood cell membranes: a dose-response study with n-3 fatty acids. “ American Journal of Clinical Nutrition 70:331-37 (1999).

Dehmer, G. J., J. J. Popma, E. K. van den Berg, E. J. Eichorn, J. B. Prewitt, W. B. Campbell, L. Jennings, J. T. Willerson, and J. M. Schmitz. "reduction in the rate of early restenosis after coronary angioplasty by a diet supplemented with n-3 fatty acids." N Engl J Med 319:733-740 (1998).

Engler M. M., Engler M. B., Pierson D. M., Molteni L. B., Molteni A. “Effects of docosahexaenoic acid on vascular pathology and reactivity in hypertension.” Laboratory of Cardiovascular Physiology, Department of Physiological Nursing, University of California, San Francisco, California 94143-0610, USA.

Eritsland, J., H. Arnesen, K. Bronseth, N. B. Fjeld, and M. Abdelnoor. "Effect of dietary supplementation with n-3 fatty acids on coronary artery bypass graft patency." Am J Cardio 77:31-36 (1996).

Eritsland, J., et al. "Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease." Blood Coagulation and Fibrinolysis  6:17-22 (1995).

Flaten, Hugo, et al. “Fish-oil concentrate: effects of variables related to cardiovascular disease.“ American Journal of Clinical Nutrition 52:300-06 (1990).

Geelen A., Brouwer I. A., Zock P. L., Kors J. A., Swenne C. A., Katan M. B., Schouten E. G. “(N-3) fatty acids do not affect electrocardiographic characteristics of healthy men and women.  J Nutr 132(10):3051-4 (2002).

GISSI-Prevenzione Investigators. "Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial." Lancet 354:447-455 (1999).

Harris, W. S., and W. L. Isley. "Clinical trial evidence for the cardioprotective effects of omega-3 fatty acids." Curr Atheroscler Rep 3:174-197 (2001).

Leaf, A., G. E. Billman, and H. Hallaq. "Prevention of ischemia-induced ventricular fibrillation by omega-3 fatty acids." Proc Nat Acad Sci USA 91:4427-4430 (1994).

Leaf, A., and J. X. Kang. "Dietary n-3 fatty acids in the prevention of lethal cardiac arrhythmias." Curr Opin Lipidol 8:4-6 (1997).

Leaf, A., J. X. Kang, Y F. Xiao, and G. E. Billman. "Dietary n-3 fatty acids in the prevention of cardiac arrhythmias." Curr Opin Clin Nutr Metab Care 1:225-228 (1998).

Marchioli, Roberto, et al. “Efficacy of n-3 polyunsaturated fatty acids after myocardial infarction: results of GISSI-Prevenzione trial. “ Lipids 36:S119-S126 (2001).

Marchioli, Roberto, et al. “Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of GISSI-Prevenzione. “ Circulation 105:1897-1903 (2002).

Morris, Martha Clare, et al. “Does fish oil lower blood pressure? A meta-analysis of controlled trials.“ Circulation 88(2):523-33 (1993).

Olszewski, A. J. "Fish oil decreases homocysteine in hyperlipidemic men." Coronary Artery Dis 4:53-60 (1993).

Radack, K. C. Deck, and G. Huster. "Dietary supplementation with low-dose fish oils lowers fibrinogen levels." Ann Intern Med 11:757-758 (1989).

Radack, Kenneth, et al. “The effects of low doses of n-3 fatty acid supplementation on blood pressure in hypertensive subjects. “ Archives of Internal Medicine 151:1173-80 (1991).

Rissanen, T. S. Voutilainen, K. Myyssonen, T.A. Lakka, and J. T. Salonen. "Fish oil-derived fatty acids, dodosahexaenoic acid, and docosapentaenoic acid, and the risk of acute coronary events: The Kuopio ischaemic heart disease risk factor study." Circulation 102:2677-2679 (2000).

Singh, Ram B., et al. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival. Cardiovascular Drugs and Therapy 11:485-91 (1997).

Von Schacky, C., P. Angerer, W. Kothny, K. Theisen, and H. Mudra. "The effect of dietary omega-3 fatty acids on coronary atherosclerosis: A randomized, double-blind placebo-controlled trial." Ann Intern Med 130:554-562 (1999).

von Schacky, Clemens. n-3 fatty acids and the prevention of coronary atherosclerosis. American Journal of Clinical Nutrition 71(suppl):S224-27S (2000).

Helps Support A Healthy Immune System

Barber, M. D., J. A. Ross, A. C. Voss, M. J. Tisdale, and K. C. Fearon. "The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer.” Br J Cancer 81:80-86 (1999).

Barber, M. D., D. C. McMillan, T. Preston, J. A. Ross, and D. C. Fearon. "Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement." Clin Sci 98:389-399 (2000).

Barber, M. D., and K. C. H. Fearon. "Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia." Lipids 36:347-351 (2001).l
Anti, Marcello, et al. “Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas.” Gastroenterology 107:1709-1718 (1994).

Bechoua, S., M. Dubois, G. Nemoz, P. Chapy, E. Vericel, M. Lagarde, and A. F. Prigent. "Very low dietary intake of n-3 fatty acids affects the immune function of healthy elderly people." Lipids 34:S143 (1999).

Endres, S., R. Ghorbani, V. E. Kelley, K. Georgilis, G. Lonnemann, J. W. van der Meer, J. G. Cannon, T. S. Rogers, M. S. Klempner, P. C. Weber, et al. "The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells." N Engl J Med 320:265-271 (1989).

Ergas D., Eilat E., Mendlovic S., Sthoeger Z. M. “n-3 fatty acids and the immune system in autoimmunity.” Isr Med Assoc J 4(1):34-8 (2002).

Fernandez, E., L. Chatenoud, C. La Vecchia, E. Negri, S. Franceschi. "Fish consumption and cancer risk." Am J Clin Nutr 70:85-90 (1999).

Gogos, C. A., P. Ginopoulos, B. Salsa, E. Apostolidou, N. C. Zoumbos, and F. Kalfarentzos. "Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: A randomized control trial." Cancer 82:395-402 (1998).

Lee, T. H., R. L. Hoover, J. D. Williams, R. I. Sperling, J. Ravalese, B. W. Spur, D. R. Robinson, E. J. Corey, R. A. Lewis, and K. P Austen. "Effect of dietary enrichment with eicosapentaenoic acid and docosahexaenoic acid on in vitro neurophil and monocyte leukotriene generation and neurophil function." N Engl J Med 312:1217-1224 (1985).

Robinson, D. R. "Alleviation of autoimmune disease by dietary lipids containing omega-3 fatty acids." Rheum Dis Clin North Am 17:213-222 (1991).

Robinson, D. R., L. L. Xu, S. Tateno, M. Guo, and R. E. Colvin. "Suppression of autoimmune disease by dietary n-3 fatty acids." J Lipid Res 34:1435-1444 (1993).

Sperling, R. I. "The effects of dietary n-3 polyunsaturated fatty acids on neutrophils." Proc Nutr Soc 57:527-534 (1998).

Terada S., Takizawa M., Yamamoto S., Ezaki O., Itakura H., Akagawa K. S. Suppressive mechanisms of EPA on human T cell proliferation.” Microbiol Immunol 45(6):473-81 (2001).

Wigmore, S. J. M. D. Barber, J. A. Ross, M. J. Tisdale, and K. C. Fearon. "Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer." Nutr Cancer 36:177-814 (2000).

Helps Maintain Cholesterol Levels That Are Already Within The Normal Range

Caron M. F., White C. M. “Evaluation of the antihyperlipidemic properties of dietary supplements.” Pharmacotherapy 21(4):481-7 (2001)..

Haglund, O., R. Wallin, R. Luostarinen, and T. Saldeen. "Effects of a new fluid fish oil concentration on triglycerides, cholesterol, fibrinogen, and blood pressure." J Intern Med 227:347-353 (1990).

Harris, W. S. "N-3 fatty acids and serum lipoproteins: Human studies." Am J Clin Nutr 65:1645S-1654S (1997).

Harris, W. S. "N-3 Fatty acids and human lioprotein metabolism: An update." Lipids 34:S257-S258 (1999).

Harris, W.S., H. N. Ginsberg, N. Arunakul, N. S. Shachter, S. L. Windsor, M. Adams, L. Berlund, and K. Osmundsen. "Safety and efficacy of Omacor in severe hypertriglyceridemia." J Cardiovasc Risk 4:385-392 (1997).

Lichtenstein A. H , Ausman L. M., Jalbert S. M., Vilella-Bach M., Jauhiainen M., McGladdery S., Erkkila A. T., Ehnholm C., Frohlich J., Schaefer E. J. “Efficacy of a Therapeutic Lifestyle Change/Step 2 diet in moderately hypercholesterolemic middle-aged and elderly female and male subjects.” J Lipid Res 43(2):264-73 (2002).

Nilsen D. W., Albrektsen G., Landmark K., Moen S., Aarsland T., Woie L. “Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol.” Am J Clin Nutr 74(1):50-6 (2001).

Puiggros C., Chacon P., Armadans L. I., Clapes J., Planas M. Effects of oleic-rich and omega-3-rich diets on serum lipid pattern and lipid oxidation in mildly hypercholesterolemic patients. Clin Nutr 21(1):79-87 (2002).

Stark, K. D., E. J. Park, V. A. Maines, and B. J. Holub. "Effect of a fish-oil concentrate on serum lipids in postmenopausal women receiving and not receiving hormone replacement therapy in a placebo-controlled, double-blind trial." Am J Clin Nutr 72:389-394 (2000).

Villa B., Calabresi L., Chiesa G., Rise P., Galli C., Sirtori C. R. “Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease. “ Department of Pharmacological Sciences, Centre E. Grossi Paoletti, University of Milan, Via Balzaretti 9, 20133 Milan, Italy.

Helps Support Healthy Joint Movement

Ariza-Ariza, R., M. Peralta-Mestanza, and M. H. Cardiel. "Omega-3 fatty acids in rheumatoid arthritis: An overview." Sem Arthr Rheum 27:366-370 (1998).

Cleland, L. G., J. K. French, W. H. Betts, G. A. Murphy, and M. J. Elliott. "Clinical and biochemical effects of dietary fish oil supplements in rheumatoid arthritis." J Rheumatol 15:1471-1475 (1988).

Curtis C. L., Rees S. G., Cramp J., Flannery C. R., Hughes C. E., Little C. B., Williams R., Wilson C., Dent C. M., Harwood J. L., Caterson B. “Effects of n-3 fatty acids on cartilage metabolism.” Proc Nutr Soc 61(3):381-9 (2002).

Espersen, G. T., N. Grunnet, H. H. Lervang, G. L. Nielsen, B. S. Thomsen, K. L. Faarvang, J. Dyerberg, and E. Ernst. "Decreased interleukin-1 beta levels in plasma from rheumatoid arthritis patients after dietary supplementation with n-3 polyunsaturated fatty acids." Clin Rheumatol 11:393-395 (1992).

Fortin, Paul R., et al. “Validation of a meta-analysis: the effects of fish oil in rheumatoid arthritis. “ Journal of Clinical Epidemiology 48:1379-90 (1995).

Geusens, P., C. Wouters, J. Nijs, Y. Jiang, and J. Dequeker. "Long-term effect of omega-3 fatty acid supplementation in active rheumatoid arthritis: A 12-month, double-blind, controlled study." Arthritis Rheum 37:824-829 (1994).

Judex S., Wohl G. R., Wolff R. B., Leng W., Gillis A. M., Zernicke R. F. “Dietary fish oil supplementation adversely affects cortical bone morphology and biomechanics in growing rabbits.” Calcif Tissue Int 66(6):443-8 (2000).

Kremer, J. M., D. A. Lawrence, W. Jubiz, R. DiGiacomo, R. Rynes, L. F. Bartholomew, and M. Sherman. "Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis: Clinical and immunologic effects." Arthritis Rheum 33:810-820 (1990).

Kremer, J. M., D. A. Lawrence, G. F. Petrillo, L. L. Litts, P. M. Mullaly, R. J. Rynes, R. P. Stocker, N. Parhami, N. S. Greenstein, and B. R. Fuchs. "Effects of high-dose fish oil on rheumatoid arthritis after stopping nonsteroidal anti-inflammatory drugs: Clinical and immune correslates." Arthritis Rheum 38:1107-1114 (1995).

Kremer, J. M. "N-3 Fatty acid supplements in rheumatoid arthritis." Am J Clin Nutr 71:349S-351S (2000).

Kremer, Joel M., et al. “Fish-oil fatty acid supplementation in active rheumatoid arthritis: A double-blinded, controlled, crossover study. “ Annals of Internal Medicine 106:497-503 (1987).

Terano, T. "Effect of omega-3 polyunsaturated fatty acid ingestion on bone metabolsim and osteoporosis." World Rev Nutr Diet 88:141-=147 (2001).

Volker, Dianne, et al. “Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. “ Journal of Rheumatology 27:2343-46 (2000).

Helps Support Healthy Kidneys

Brown, S. A., C. A. Brown, W. A. Crowell, J. A. Barsanti, T. Allen, C. Cowell, and D. R. Finco. "Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency." J Clin Lab Med 131:447-455 (1998).

Brown, S. A., C. A. Brown, W. A. Crowell, J. A. Barsanti, C-W. Kang, T. Allen, C. Cowell, and D. R. Finco. "Effects of dietary polyunsaturated fatty acids supplementation in early renal insufficiency in dogs." J Lab Clin Med 135:275-286 (2000).

Cappelli P., Di Liberato L., Stuard S., Ballone E., Albertazzi A. “N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease.” J Nephrol 10(3):157-62 (1997).

Clark, W. F., A Parbtani, C. D. Naylor, C. M. Levinton, N. Muirhead, E. Spanner, M. W. Huff, D. J. Philbrick, and B. J. Holub. "Fish oil in lupus nephritis: Clinical findings and methodological implications." Kidney Int 44:75-86 (1993).

Donadio, J. V., E. J. Bergstralh, K. P. Offord, D. C. Spencer, and D. E. Holley. "A controlled trial of fish oil in IgA nephropathy." N Engl J Med 331:1194-1199 (1994).

Donadio, J. V., J. P. Grande, E. J. Bergstralh, R. A. Dart, T. S. Larson, and D. C. Spencer. "The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial." J Am Soc Nephrol 10:1772-1777 (1999).

Lenin M., Thiagarajan A., Nagaraj M., Varalakshmi P. “Attenuation of oxalate-induced nephrotoxicity by eicosapentaenoate-lipoate (EPA-LA) derivative in experimental rat model.”  Department of Medical Biochemistry, University of Madras, India.

Pettersson E. E., Rekola S., Berglund L., Sundqvist K. G., Angelin B., Diczfalusy U., Bjorkhem I., Bergstrom J. “Treatment of IgA nephropathy with omega-3-polyunsaturated fatty acids: a prospective, double-blind, randomized study.” Clin Nephrol 41(4):183-90 (1994).

Prickett, J. D., D. R. Robinson, and A. D. Steinberg. "Dietary enrichment with polyunsaturated acid eicosapentaenoic acid prevents proteinuria and prolongs survival in NZBxNZW F1 mice." J Clin Invest 68:556-559 (1981).

Sulikowska B., Manitius J., Nieweglowski T., Szydlowska-lysiak W., Rutkowski B. “The effect of therapy with small doses of mega-3 polyunsaturated fatty acid on renal reserve and metabolic disturbances in patients with primary IGA glomerulopathy.” Pol Arch Med Wewn 108(2):753-60 (2002).

Helps Support Balanced Mood and Sense of Well Being

Adams. P., S. Lawson, A. Sanigorski, and A.J. Sinclair. "Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression." Lipids 31:S157-S161 (1996).

Burgress, J. R., L. Stevens, and L. Peck. "Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder." Am J Clin Nutr 71:327S-330S (2000).

Hamazaki, T., S. Sawazaki, M. Itomura, E. Asaoka, Y. Nagao, N. Nishimura, K. Yazawa, T. Kuwamori, and M. Kobayashi. "The effect of docosahexaenoic acid on aggression in young adults." J Clin Invest 97:1129-1134 (1996).

Hamazaki, T., S. Sawazaki, M. Itomura, Y. Nagao, A. Thienprasert, T. Nagasawa, and S. Watanabe. "Effect of docosahexaenoic acid on hostility." World Rev Nutr Diet 88:47-52 (2001).

Hamazaki, T., S. Sawazaki, T. Nagasawa, Y. Nagao, Y Kanagawa, and K. Yazawa. "Administration of docosahexaenoic acid influences behavior and plasma catecholamine levels at time of psychological stress." Lipids 34:S33-S37 (1999).

Hamazaki, T., M. Itomura, S. Sawazaki, and Y. Nagao. "Anti-stress effects of D. H. A." Biofactors 13:41-45 (2000).

Hamazak T., Thienprasert A., Kheovichai K., Samuhaseneetoo S., Nagasawa T., Watanabe S. “The effect of docosahexaenoic acid on aggression in elderly Thai subjects--a placebo-controlled double-blind study.” Nutr Neurosc 5(1):37-41 (2002).

Maes, M. "Fatty acid composition in major depression: Decreased n-3 fractions in cholesterol esters and increased C20:46/C20:5n3 ratio in cholester ester and phosopholipds. J Affect Dis 38:35-46 (1996).

Maes, M., A Christophe, J. Delanghe, C. Altamura, H. Neels, and H.Y. Meltzer. "Lowered omega-3 polyunsaturated fatty acids in serum phospholipids and cholesterol esters of depressed patients." Psychiatry Res 85:275-291 (1999).

Mills, D. E., K. M. Prkochin, K. A. Harvey, and R. P. Ward. "Dietary fatty acid supplementation alters stress reactvity and performance in man." J Human Hypertension 3:111-116 (1989).

Peet, M., J. Brind, C. N. Ramchand, S. Shah, and G. K. Vankar. "Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia." Schizophr Res 49:243-251 (2001).

Richardson, A.J., et al. “Red cell and plasma fatty acid changes accompanying symptom remission in a patient with schizophrenia treated with eicosapentaenoic acid. “ European Neuropsychopharmacology 10 :189-93 (2000).

Stoll, Andrew L., et al. “Omega 3 fatty acids in bipolar disorder.” Archives of General Psychiatry 56:407-12 (1999).

Stoll, A. L., E. Severus, M. P. Freeman, S. Reuter, H. A. Zhoyan, E. Diamond, K. K. Cress, and L. B. Marangell. "Omega-3 fatty acids in bipolar depression: A preliminary double-blind placebo-controlled trial." Arch Gen Psychiatry 56:407-412 (1999).

Voigt, R. G., A. M. Llorente, C. L. Jensen, J. K. Fraley, M.C. Berretta, and W. C. Heird. "A randomized, double-blind, placebo-controlled trial of docosahexaenoic acid supplementation in children with attention-deficit/hyperactivity disorder." J Pediatr 139:189-196 (2001).

Yehuda, S., S. Rabinovitz, R. L. Carasso, and D. I. Mostofsky. "Essential Fatty acid preparation improves Alzheimer's patients' quality of life." Int J Neurosci 87:141-149 (1996).

Helps Support Strength and Stamina

Bruckner, G., P. Webb, L. Greenwell, C. Chow, and D. Richardson. "Fish oil increases peripheral capillary blood cell velocity in humans." Atherosclerosis 66:237-245 (1987).

Muoio, D. M., J. J. Leddy, P. J. Horvath, A. B. Awad, and D. R. Pendergast. "Effect of dietary fat on metabolic adjustments to maximal VO2 and endurance in runner." Med Sci Sports Exerc 26:81-88 (1994).

Pendergast, D. R., P. J. Horvath, J. J. Leddy, and J. T. Venkatraman. "The role of dietary fat in performance, metabolism, and health." Am J Sports Med 24:S53-S58 (1996).

Raastad T., Hostmark A. T., Stromme S. B. “Omega-3 fatty acid supplementation does not improve maximal aerobic power, anaerobic threshold and running performance in well-trained soccer players.” Scand J Med Sci Sports 7(1):25-31 (1997).

Salachas, Anastasios, et al. “Effects of low-dose fish oil concentrate on angina, exercise tolerance time, serum triglycerides, and platelet function. “ Angiology 45:1023-31 (1994).

Although there is no established RDA for Omega-3 Fatty Acids (EPA and DHA), much of the medical research on the health benefits of these nutrients is conducted using amounts of 1,000 mg and up.*

So, what does it really cost you for 1,000 mg
of Omega-3's (DHA/EPA)?

Product
Name Mg of Omega-3's
(EPA & DHA)
Per Capsule # Caps
in a Bottle Mg Per
Bottle Cost Per
Bottle Cost for 1,000 Mg of Omega-3's
(EPA & DHA) OmegaRx™
Ultra-Refined
Fish Oil Capsules
(pharmaceutical grade) 600 120 72,000 $40.00**
$0.56 Triomega Omega-3
(Pronova Biocare) 500 60 30,000 $19.99 $0.67 Omega Brite
(Omega Natural Science) 430 60 25,800 $18.99 $0.74 Ultimate Omega
(Nordic Naturals) 600 60 36,000 $26.95 $0.75 Omega-3
(Nordic Naturals) 300 60 18,000 $13.95 $0.78 Essential Oils Formula Large
(Atkins) 240 120 28,800 $23.79 $0.83 The Total EFA
(Health from the Sun) 118 90 10,620 $9.82 $0.92 Omega 3 & E
(Living Fuel) 200 120 24,000 $34.97 $1.46 Maximum Strength Omega-3
1 Buy 3 (Iceland Health) 500 30 15,000 $33.30 $2.22 Maximum Strength Omega-3
Buy 1 (Iceland Health) 500 30 15,000 $49.95 $3.33

The information for this comparison was acquired from reputable Internet web sites on July 28 and 29, 2004 and Sept. 21, 2004. This comparison chart focuses on the cost of 1,000 mg of Omega-3's (EPA and DHA) only. Although some of the products used in this comparison contain additional ingredients that may be beneficial to your health, only the cost of the long-chain Omega-3's (EPA and DHA) were calculated.

*GISSI-Prevenzione Investigators. "Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial." Lancet 354:447-455 (1999). This study was conducted using approximately 1,000 mg of Omega-3 fatty acids.

** ZoneNet Autoship price.

Fish Oil Types Comparisions Cod Liver Oil   Health Food Grade
Fish Oil   OmegaRx™ Ultra-refined
Fish Oil Not Safe at
High Levels   Questionable If Safe
at High Levels   Safe at
High Levels Highest levels of contaminants (organic mercury, PCB's and DDT).   Typical health-food grade omega-3 fish oil supplements contains varying amounts of contaminants. In addition, the fractional cooling method does not remove the PCB's or the long-chain monoene fatty acids that give rise to significant gastric distress.   It is so pure and refined, OmegaRx contains 100s times less PCB's and other contaminants than health food grade omega-3 fish oil. Low Quality   Better Quality   Highest Quality
Ultra-refined This is what Grandma used to give your parents. It is the lowest quality of all fish oils. Taking a high-dosage of cod liver oil is not recommended due to the high levels of Vitamin A and contaminants found in this form of fish oil.   If the label says the oil comes from a particular species of fish such as salmon oil then you know it is health-food grade omega-3 fish oil supplement. These oils are only sold in soft gelatin capsules because they still have an extremely poor taste profile.

There is a slightly more purified type of health food grade fish oil that includes those that have been subjected to a very limited amount of molecular distillation to remove some of the cholesterol in order to be labeled "cholesterol-free".

There is also another type of higher-grade health-food fish oil known as "fish oil concentrate." This type of fish oil consists of ethyl esters of the fish oil that has been subjected to fractional cooling.

  OmegaRx™ starts with the highest health food grade omega-3 fish oil and then goes through the following painstaking refining processes:

Additional amounts of saturated fats are removed by winterization at a very low temperature.

True molecular distillation process, the final refining process assures removal of all man made pollutants such as mercury, PCB's and dioxins.

Rigorous analysis and certification by an Independent Laboratory before product formulation.  The result is highly purified fish oil supplement.

Potency   Potency   Potency A typical one-teaspoon serving of cod liver oil contains only 500 mg. of long-chain omega 3 fatty acids.   A typical one-gram capsule of health-food grade fish oil contains approximately 300 mg. of long-chain omega 3 fatty acids.

A one-gram capsule of thermally fractionated health-food grade omega 3 fish oil supplements may contain up to 500 mg. of long-chain omega 3 fatty acids.   A one-gram capsule of OmegaRx Ultra Refined Fish Oil contains 600 mg. of long-chain omega-3 fatty acids with 5 I.U. of Vitamin E per gram of omega 3 fish oil.

It has twice the EPA and DHA as found in health-food grade fish oil.

One teaspoon of the liquid OmegaRxTM contains 1.8 grams of EPA and  0.9 grams of DHA.

How many grams of long-chain Omega-3 fatty acids are found in a single capsule of OmegaRx™?

Each OmegaRx™ capsule contains 600 mg. of long-chain omega-3 fatty acids. This is double the amount found in health-food grade fish oil capsules. Four OmegaRx™ capsules would supply 2.4 grams of long-chain omega-3 fatty acids, which is similar to that found in one tablespoon of cod liver oil.

How many grams of long-chain Omega-3 fatty acids are in a teaspoon of OmegaRx™?

One teaspoon of liquid OmegaRx™ contains 2.7 grams of long-chain omega-3 fatty acids. This is slightly more than one tablespoon of cod liver oil. This is equivalent to taking nine (9) capsules of typical health-food grade fish oil. Each teaspoon of OmegaRx™ contains 1800 mg. (1.8 g) of EPA and 900 mg. (0.9 g) of DHA.

Why this particular ratio of EPA and DHA?

The 2:1 ratio of EPA and DHA in OmegaRx™ is virtually the same as that used in all scientific studies conducted with OmegaRx™ Fish Oil reporting health benefits.

How much OmegaRx™ should I take?

A good maintenance dose is 2.5 grams of long-chain omega-3 fatty acids each day. This dosage represents either four OmegaRx™ capsules or one teaspoon of the liquid OmegaRx™. This is the amount found in a tablespoon of cod liver oil. Most people will find that the capsules are the preferred choice for daily supplementation of OmegaRx™ fish oil because of their ease of use. Individuals who will use the liquid OmegaRx™ are those who require higher amounts of long-chain omega-3 fatty acids, and find taking the liquid easier than taking large numbers of capsules.

Why is OmegaRx™ the best value?

To manufacture OmegaRx™ fish oil requires extensive purification. In fact, it takes 100 gallons of health-food grade fish oil to make one gallon of this Pharmaceutical-Grade fish oil. Only this superior grade material makes high-dose supplementation possible due to lack of toxins and gastric distress common with other fish oils at recommended dose levels.

How should I store the OmegaRx™ capsules?

Soft gelatin capsules are best stored between 59 and 75 degrees in a dry, dark container. This is why each container contains an absorbent to maintain a defined degree of humidity. The shelf life of the capsules is two years under these conditions.

How should I store the OmegaRx™ oil?

After opening the liquid OmegaRx™, carefully remove the plug, and then discard it. Put the bottle in the freezer to maintain its potency. Always shake the container well before using to better disperse the flavor. The liquid OmegaRx™ has a one-year shelf life under these conditions.

What does liquid OmegaRx™ taste like?

Liquid OmegaRx™ has remarkably little taste or odor, especially when kept in the freezer. However, here are some additional tips to improve taste:

Eat a small piece of citrus fruit (lime, lemon, or orange) with the oil. The citrus flavor will mask any residual taste.
Have a sip of a cup of decaffeinated coffee with OmegaRx™.

Make a Big Brain Shake with 2 cups of berries, 30 grams of protein powder and 1-3 teaspoons of OmegaRx™. The protein powder will emulsify the oil plus you instantly create a Zone meal that includes your daily supplementation with OmegaRx oil.

Take 1/2 a serving of an OmegaZone™ Lemon Chiffon meal replacement bar, then take your Omega Rx™ and eat the remainder of the OmegaZone™.   This will completely eliminate any taste.  By doing so, you have a very quick Zone meal with your daily dose of Omega Rx™ fish oil. This is the ideal way to start the day.